Such therapy-induced antitumor CD8 T cell response is shaped by a spectrum of tumor antigens (i.e., it is polyclonal), can act on existing cancer cells, and maintain antigen-specific memory response against tumor challenge or relapse (2, 3, 4, 5). Here, CD8A is linked to neoplasm.